Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown benefits for cardiorenal outcomes in patients with type 2 diabetes mellitus. Although some observational studies suggest that GLP-1RAs protect against arrhythmias, the evidence remains inconclusive. Methods This stud...

Cijeli opis

Bibliografski detalji

Glavni autori:	Xinyi Zhang, Nanqin Peng, Xiaoyue Zhang, Zicheng Zhu, Yan Miao, Yuting Wu, Jitao Ling, Chen Li, Wenli Gu, Jing Zhang, Abudukeremu Ayiguli, Ziheng Zheng, Peng Yu, Xiao Liu
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-05-01
Serija:	Diabetology & Metabolic Syndrome
Teme:	Glucagon-like peptide-1 receptor agonists Atrial fibrillation Cardiac arrest Ventricular fibrillation Mendelian randomization
Online pristup:	https://doi.org/10.1186/s13098-025-01712-w
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!